Clinical trials
Phase 3 Multiple Sclerosis trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
49 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2004 | 1 |
| 2006 | 4 |
| 2007 | 3 |
| 2008 | 4 |
| 2009 | 3 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 4 |
| 2018 | 1 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 2 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 29 |
| Terminated | 9 |
| Active, not recruiting | 7 |
| Recruiting | 3 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Biogen | 9 |
| Novartis Pharmaceuticals | 9 |
| Sanofi | 6 |
| Hoffmann-La Roche | 4 |
| Actelion | 3 |
| Genzyme, a Sanofi Company | 3 |
| Teva Branded Pharmaceutical Products R&D, Inc. | 3 |
| Merck KGaA, Darmstadt, Germany | 2 |
| Almirall, S.A. | 1 |
| Bayer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Sclerosis | 49 |
| Multiple Sclerosis, Relapsing-Remitting | 13 |
| Recurrence | 6 |
| Multiple Sclerosis, Chronic Progressive | 4 |
| Anxiety Disorders | 1 |
| Muscle Spasticity | 1 |
| Neoplasm Metastasis | 1 |
| Stress Disorders, Post-Traumatic | 1 |
| Thinness | 1 |
Trials
Showing 1 to 25 of 49. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.